What is RDHL's revenue growth forecast for 2025-2025?
(NASDAQ: RDHL) Redhill Biopharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Redhill Biopharma's revenue in 2025 is $9,550,000.
In 2025, RDHL is forecast to generate $499,997,449,560 in revenue, with the lowest revenue forecast at $480,389,706,440 and the highest revenue forecast at $514,703,256,900.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.